Mayo Clinic Infectious Diseases Board Review

ISBN : 9780199827626

Zelalem Temesgen
584 Pages
204 x 275 mm
Pub date
Oct 2011
Send mail

Infectious diseases is an area of medicine that has always been relevant and important in all regions of the world. In recent years, the relevance and importance have been emphasized and heightened by a number of issues, including the emergence of new infections (such as HIV, the novel H1N1 influenza pandemic, avian flu, and severe acute respiratory syndrome) as well as increasing resistance to current established treatments of various infections (such as those caused by Streptococcus pneumoniae, Staphylococcus aureus, Enterococcus species, several gram-negative bacteria, and Mycobacterium tuberculosis). There is a need to provide accurate and up-to-date information to infectious diseases practitioners who are at the front line of the effort against these problems. Mayo Clinic Infectious Diseases Board Review is a comprehensive, state-of-the-art publication. Written by practicing Mayo Clinic infectious diseases specialists, the book covers current and essential clinical aspects of diseases likely to be encountered by the infectious diseases specialist as well as to appear on the subspecialty infectious diseases board examination. Relevant and practical information is presented in an uncluttered format with liberal use of tables, diagrams, algorithms, and images as appropriate. While the primary audience of the book is practicing infectious diseases specialists preparing for their subspecialty board examination, the broader utility of this publication will include its use as an update for infectious diseases physicians, as a teaching curriculum in infectious diseases training programs, and as a user-friendly and practical resource in infectious diseases for noninfectious diseases physicians and health care providers. This publication will be a useful resource not only in the United States but throughout the world.


Table of Contents
Section I: General
1 Pharmacokinetics and Pharmacodynamics of Antimicrobials Lynn L. Estes, PharmD, RPh
2 Antimicrobials Lynn L. Estes, PharmD, RPh, and John W. Wilson, MD
3 Health Care-Associated Infection Prevention and Control Programs W. Charles Huskins, MD
4 Mycobacterial and Fungal Diagnostic Matthew J. Binnicker, PhD, Glenn D. Roberts, PhD, and Nancy L. Wengenack, PhD
Questions and Answers
Section II: Etiologic Agents
5 Select Viruses in Adults Randall C. Walker, MD
6 Select Gram-positive Aerobic Bacteria Robin Patel, MD
7 Select Gram-negative Aerobic Bacteria David R. McNamara, MD, and Franklin R. Cockerill III, MD
8 Select Anerobic Bacteria: Clostridium tetani and Clostridium botulinum M. Rizwan Sohail, MD
9 Borrelia and Leptospira Species Julio C. Mendez, MD
10 Tick-Borne Infections Alan J. Wright, MD
11 Mycobacteria Irene G. Sia, MD
12 Nocardia and Actinomyces Christine L. Terrell, MD
13 Candida Species Shimon Kusne, MD, and Ann E. McCullough, MD
14 Aspergillus Species Shimon Kusne, MD, and Ann E. McCullough, MD
15 Histoplasma capsulatum Janis E. Blair, MD
16 Blastomyces dermatitidis Janis E. Blair, MD
17 Coccidioides Species Janis E. Blair, MD
18 Paracoccidioides brasiliensis Janis E. Blair, MD
19 Sporothrix schenckii Janis E. Blair, MD
20 Cryptococcus neoformans Shimon Kusne, MD, and Ann E. McCullough, MD
21 Emerging Fungal Infections Holenarasipur R. Vikram, MD, FACP, FIDSA
22 Parasitic Infections Jon E. Rosenblatt, MD, and Bobbi S. Pritt, MD
Questions and Answers
Section III: Select Major Clinical Syndromes
23 Fever of Unknown Origin Mary J. Kasten, MD
24 Infections of the Oral Cavity, Neck, and Head Lisa M. Brumble, MD
25 Pneumonia Priya Sampathkumar, MD
26 Urinary Tract Infections Walter C. Hellinger, MD
27 Sepsis Syndrome Andrew D. Badley, MD
28 Infectious Diarrhea Robert Orenstein, DO
29 Intra-abdominal Infections Robert Orenstein, DO
30 Viral Hepatitis Stacey A. Rizza, MD
31 Infective Endocarditis Larry M. Baddour, MD, and Daniel Z. Uslan, MD
32 Infections of the Central Nervous System Michael R. Keating, MD
33 Skin and Soft Tissue Infections Imad M. Tleyjeh, MD, MSc, and Larry M. Baddour, MD
34 Osteomyelitis, Infectious Arthritis, and Orthopedic Device Infection Elie F. Berbari, MD, and Douglas R. Osmon, MD
35 Sexually Transmitted Diseases Randall S. Edson, MD
Questions and Answers
Section IV: Special Hosts and Situations
36 Human Immunodeficiency Virus Infection Zelalem Temesgen, MD
37 HIV-Associated Opportunistic Infections and Conditions Anne M. Meehan, MB, BCh, PhD, and Eric M. Poeschla, MD
38 Infections in Patients With Hematologic Malignancies John W. Wilson, MD, and Michelle A. Elliott, MD
39 Infections in Transplant Recipients Raymund R. Razonable, MD
40 Health Care-Associated Infections Rodney L. Thompson, MD, and Priya Sampathkumar, MD
41 Obstetric and Gynecologic Issues Related to Infectious Diseases Kristi L. Boldt, MD
42 Pediatric Infectious Diseases Thomas G. Boyce, MD
43 Travel Medicine Abinash Virk, MD
44 Adult Immunizations Priya Sampathkumar, MD
45 Agents of Bioterrorism Mark P. Wilhelm, MD, FACP
Questions and Answers

About the author: 

Zelalem Temesgen, MD, is a professor of medicine and a consultant in the Division of Infectious Diseases at Mayo Clinic in Rochester, Minnesota. He established the HIV Clinic at Mayo Clinic and is currently the director of the HIV program as well as the director of the Mayo Clinic Global HIV Education Initiative. Dr. Temesgen is board certified in infectious diseases and is certified as an HIV specialist by the American Academy of HIV Medicine. In addition to his clinical duties, Dr Temesgen is actively involved in education both within Mayo Clinic and extramurally. His educational activities include media presentations, extramural visiting professorships, and invited lectures at national and international meetings.

The price listed on this page is the recommended retail price for Japan. When a discount is applied, the discounted price is indicated as “Discount price”. Prices are subject to change without notice.